Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$13.7K Sell
15,752
-15,020
-49% -$11.9K ﹤0.01% 884
2026
Q2
$26.8K Buy
+30,772
New +$38.6K ﹤0.01% 933
2025
Q3
– Sell
-10,604
Closed -$7.58K – 346
2025
Q2
$7.58K Buy
10,604
+530
+5% +$376 ﹤0.01% 285
2025
Q1
$6.1K Buy
+10,074
New +$9.04K ﹤0.01% 198

Other funds holding IVVD

Abel Hall LLC's IVVD Position: Q3 2026 in Review

Abel Hall LLC reduced its Invivyd (IVVD) stake by 49% in Q3 2026, selling an estimated $11.9K and leaving 15,752 shares worth $13.7K. The position accounts for ﹤0.01% of the portfolio, ranked #884.

Abel Hall LLC first reported a position in IVVD in Q1 2025 and has held it in 4 quarters since. The position peaked at $26.8K in Q2 2026. 7 funds tracked by Wall St. Rank hold IVVD as of Q3 2026.

  • Abel Hall LLC held 15,752 shares of Invivyd worth $13.7K as of Q3 2026.
  • Abel Hall LLC sold 15,020 Invivyd shares in Q3 2026, an estimated $11.9K.
  • Invivyd made up ﹤0.01% of Abel Hall LLC's portfolio in Q3 2026, its #884 holding.
  • Abel Hall LLC first reported a position in Invivyd in Q1 2025 and has held it in 4 quarters since.
  • Abel Hall LLC's Invivyd position peaked at $26.8K in Q2 2026.
  • 7 funds tracked by Wall St. Rank held Invivyd as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.